Molecular Monitoring of Chronic Myelogenous Leukemia

This publication has 29 references indexed in Scilit:

• β-Glucuronidase Is an Optimal Normalization Control Gene for Molecular Monitoring of Chronic Myelogenous Leukemia
  The Journal of Molecular Diagnostics, 2006
• Discontinuation of imatinib therapy after achieving a molecular response
  Blood, 2004
• Molecular response to imatinib in late chronic-phase chronic myeloid leukemia
  Blood, 2004
• Molecular monitoring of response to imatinib (Glivec®) in CML patients pretreated with interferon alpha. Low levels of residual disease are associated with continuous remission
  Leukemia, 2003
• Comprehensive Validation of a Real-Time Quantitative bcr-abl Assay for Clinical Laboratory Use
  American Journal of Clinical Pathology, 2003
• Quantitative real‐time reverse‐transcription polymerase chain reaction for diagnosis of BCR‐ABL positive leukemias and molecular monitoring following allogeneic stem cell transplantation
  European Journal of Haematology, 2003
• Comparison of chromosome banding analysis, interphase- and hypermetaphase-FISH, qualitative and quantitative PCR for diagnosis and for follow-up in chronic myeloid leukemia: a study on 350 cases
  Leukemia, 2002
• Monitoring chronic myeloid leukaemia therapy by real‐time quantitative PCR in blood is a reliable alternative to bone marrow cytogenetics
  British Journal of Haematology, 1999
• Accurate and rapid analysis of residual disease in patients with CML using specific fluorescent hybridization probes for real time quantitative RT-PCR
  Leukemia, 1999
• Detection of BCR-ABL transcripts in chronic myeloid leukemia (CML) using a ‘real time’ quantitative RT-PCR assay
  Leukemia, 1999